162 related articles for article (PubMed ID: 19860543)
21. Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9.
Mhatre AN; Kim Y; Brodie HA; Lalwani AK
Otol Neurotol; 2003 Mar; 24(2):205-9. PubMed ID: 12621333
[TBL] [Abstract][Full Text] [Related]
22. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature.
Ishida M; Mori Y; Ota N; Inaba T; Kunishima S
Clin Nephrol; 2013 Sep; 80(3):218-22. PubMed ID: 22541678
[TBL] [Abstract][Full Text] [Related]
23. MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation.
Economou M; Batzios SP; Pecci A; Printza N; Savoia A; Barozzi S; Theodoridou S; Teli A; Psillas G; Zafeiriou DI
J Pediatr Hematol Oncol; 2012 Aug; 34(6):412-5. PubMed ID: 22627578
[TBL] [Abstract][Full Text] [Related]
24. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
[TBL] [Abstract][Full Text] [Related]
25. A Japanese pedigree with a p.A95V mutation in the MYH9 gene demonstrates inherited macrothrombocytopenia without Alport manifestations.
Yokoi S; Kunishima S; Takahashi Y; Morishita M; Kojima S
Ann Hematol; 2016 Apr; 95(5):831-3. PubMed ID: 26861218
[No Abstract] [Full Text] [Related]
26. Megakaryocyte and platelet abnormalities in a patient with a W33C mutation in the conserved SH3-like domain of myosin heavy chain IIA.
Kahr WH; Savoia A; Pluthero FG; Li L; Christensen H; De Rocco D; Traivaree C; Butchart SE; Curtin J; Stollar EJ; Forman-Kay JD; Blanchette VS
Thromb Haemost; 2009 Dec; 102(6):1241-50. PubMed ID: 19967157
[TBL] [Abstract][Full Text] [Related]
27. High-resolution melting analysis for detection of MYH9 mutations.
Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
[TBL] [Abstract][Full Text] [Related]
28. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
Seri M; Pecci A; Di Bari F; Cusano R; Savino M; Panza E; Nigro A; Noris P; Gangarossa S; Rocca B; Gresele P; Bizzaro N; Malatesta P; Koivisto PA; Longo I; Musso R; Pecoraro C; Iolascon A; Magrini U; Rodriguez Soriano J; Renieri A; Ghiggeri GM; Ravazzolo R; Balduini CL; Savoia A
Medicine (Baltimore); 2003 May; 82(3):203-15. PubMed ID: 12792306
[TBL] [Abstract][Full Text] [Related]
29. MYH9-related platelet disorders.
Althaus K; Greinacher A
Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
[TBL] [Abstract][Full Text] [Related]
30. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
[TBL] [Abstract][Full Text] [Related]
31. [Genetic analysis of a pedigree affected with inherited thrombocytopenia caused by a novel mutation of MYH9 gene].
Liao W; Luo X; Zhang X; Chen P; Wu H; Shu W; Yuan Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):352-356. PubMed ID: 28604953
[TBL] [Abstract][Full Text] [Related]
32. MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.
Pecci A; Ma X; Savoia A; Adelstein RS
Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756
[TBL] [Abstract][Full Text] [Related]
33. Mutations in MYH9 exons 1, 16, 26, and 30 are infrequently found in Japanese patients with nonsyndromic deafness.
Kunishima S; Matsunaga T; Ito Y; Saito H
Genet Test Mol Biomarkers; 2009 Oct; 13(5):705-7. PubMed ID: 19645626
[TBL] [Abstract][Full Text] [Related]
34. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
Arrondel C; Vodovar N; Knebelmann B; Grünfeld JP; Gubler MC; Antignac C; Heidet L
J Am Soc Nephrol; 2002 Jan; 13(1):65-74. PubMed ID: 11752022
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of neutrophil non-muscle myosin heavy chain-IIA immunofluorescence analysis in determining the pathogenicity of MYH9 variants.
Kunishima S; Yusuke O; Muramatsu H; Kojima D; Nagai N; Takahashi Y; Kojima S
Ann Hematol; 2017 Jun; 96(6):1065-1066. PubMed ID: 28293712
[No Abstract] [Full Text] [Related]
36. [Clinical features and genetic analysis of a pedigree affected with non-muscle myosin heavy chain 9 gene related disease].
Zeng Q; Han Y; Huang L; Ji H; Du Y; Yang N; Xu Q; Huang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Apr; 36(4):352-356. PubMed ID: 30950024
[TBL] [Abstract][Full Text] [Related]
37. MYH9-related disease: description of a large Chinese pedigree and a survey of reported mutations.
Zhang S; Zhou X; Liu S; Bai T; Zhang Y; Wang J; Wang S; Zhang X; Wang B
Acta Haematol; 2014; 132(2):193-8. PubMed ID: 24643058
[TBL] [Abstract][Full Text] [Related]
38. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
[TBL] [Abstract][Full Text] [Related]
39. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.
Sekine T; Konno M; Sasaki S; Moritani S; Miura T; Wong WS; Nishio H; Nishiguchi T; Ohuchi MY; Tsuchiya S; Matsuyama T; Kanegane H; Ida K; Miura K; Harita Y; Hattori M; Horita S; Igarashi T; Saito H; Kunishima S
Kidney Int; 2010 Jul; 78(2):207-14. PubMed ID: 20200500
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation].
Böttcher A; Knecht R; Busch CJ; Lörincz BB; Dalchow CV
HNO; 2013 Feb; 61(2):159-60, 162-5. PubMed ID: 23223919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
